Mirataz ® (mirtazapine transdermal ointment) is for topical use in cats only under veterinary supervision. Do not use in cats with a known hypersensitivity to mirtazapine or any of the excipients.
Mirataz was safe and well tolerated in clinical studies In clinical studies, Mirataz was well tolerated and used in cats with unintended weight loss associated with a variety of underlying conditions.
Mirataz is classified as a weight gain drug. Mirataz is the first and only FDA-approved transdermal medication for the management of weight loss in cats. Mirataz is a practical way to help cats gain weight without administration of oral medications and does not rely on your cat to eat to be medicated.
Mirataz was effective in the management of weight loss in cats associated with a wide variety of conditions 2 Mirataz is indicated for the management of weight loss in cats.
Mirataz ® (mirtazapine transdermal ointment) is for topical use in cats only under veterinary supervision. Do not use in cats with a known hypersensitivity to mirtazapine or any of the excipients. Do not use in cats treated with monoamine oxidase inhibitors (MAOIs). Not for human use. Keep out of reach of children. Wear gloves when handling/applying, wash hands after and avoid contact between ...
Nasdaq: Kindred Biosciences Announces Positive Opinion from CVMP in the European Union for Mirataz® (mirtazapine transdermal ointment) for Cats Experiencing Poor Appetite and Weight Loss
Kindred Biosciences Announces Positive Opinion from CVMP in the European Union for Mirataz® (mirtazapine transdermal ointment) for Cats Experiencing Poor Appetite and Weight Loss
Reuters: Kindred Biosciences Receives FDA Approval Of Mirataz For The Management Of Weight Loss In Cats